Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Leber LauraChief Communication Officer2017-03-20Sell3,07214,627$31.8897.94-2.5114,627 (Direct)
Cole G BradleyCOO2017-03-08Sell5,71039,528$31.55180.15-1.4939,528 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2017-03-06Sell5,000308,210$31.09155.45-0.0378,236 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Shak StevenChief Scientific Officer2017-02-23Sell5,000331,103$29.36146.85.86331,103 (Direct)
Febbo Phillip G.Chief Medical Officer2017-02-16Sell2,49520,644$30.0975.073.2920,644 (Direct)
Cole G BradleyCOO2017-02-15Sell5,00039,728$291457.1739,728 (Direct)
Shak StevenChief Scientific Officer2017-01-23Sell5,000327,207$27.28136.413.93327,207 (Direct)
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.16.3735,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.051.5435,882 (Direct)
Popovits Kimberly JPresident and CEO2016-12-05Sell5,000289,594$30.02150.13.5359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-2.0514,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-1.99327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.44.7235,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.447.6259,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.952.27327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.591.635,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.044.7226,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.1515.84327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.6413.3935,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.214.1327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.02270215.03
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.357.6635,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.228.1429,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.113.35327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.216.6735,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8520.61327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.116.7535,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.921132,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.613812.6134,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.0114.2615,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28561131,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.322.22326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.081124,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-3.36,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-1.9227,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-7.5824,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.046.2227,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.195.9712,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.665.9724,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1219.430,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9822.630,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.1212.930,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9618.4530,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.1612.8529,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-0.64Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.762.129,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-2.6Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-2.3929,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.584.09Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-0.9221,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-2.666,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-7.11Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-5.79Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-4.4321,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-10.74Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-12.0822,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-14.246,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.340.97Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.088.0322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.464.23Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.423.2922,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.213.6312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2119.22Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.7716.89Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.2214.922,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$2718915.11312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1116.27312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.319.08Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.4812.5324,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.7813.8922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6217.11Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3623.8723,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7518.4311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$278115.1122,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.529.59311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.2811.9622,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.5811.4815,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.6613.51311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$278115.1124,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-1.36308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$30753.6Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.5110.3318,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.985.11308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.71.3Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-6.5321,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-116,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-10.12Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-6.8321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-0.9618,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.354.75308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$30753.6Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.883.7718,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-7.86313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-9.41Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-4.4618,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-5.5321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-1.36,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-5.76318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-5.9Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-6.2421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-6.2421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-7.6619,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-12.03318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-10.2Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-8.0717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-8.0717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-6.7513,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-7.28323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-12.89Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-13.3817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-14.7813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-14.05
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-15.34
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-14.626,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-15.75
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-15.84
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-17.087,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-16.43327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-14.73
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-13.266,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-9.49
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-9.77,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-10.43Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-13.7117,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-13.6412,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$30753.6Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.4811.8412,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.438.7912,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.5811.88
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.410.497,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.59.442,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.969.13
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.5310.41
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.0810.8814,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.548.036,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.51117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.711.4814,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.712.04333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.9511.84Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28841117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.6811.646,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1215.84288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.715.37338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.2615.5836,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.5213.76288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.214.1Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.111.76288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28841117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.558.614,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-6.05Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-11.83343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-8.0217,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-7.9911,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-10.6914,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-7.94348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-1.92Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-11.2314,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-11.72,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-11.17353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-10.48Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.231.9414,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-13.436,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-9.23358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-10.59Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-12.18Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-13.5514,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-6.53363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-6.83Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-6.83Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-7.33Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-8.5113,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-8.05367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-3.66
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-5.926,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-8.26
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-9.2Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-7.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.043.74
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.62.85Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.187.6613,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.699.24
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.4210.176,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.6511.28372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.9511.84Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.9811.0818,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.88.71Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.72.6413,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.43.32377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.353.36Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.353.36Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.43.32377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08019,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.50.1Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.853.8113,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.743.22
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.093.22
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.093.22
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.14.26
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.374.26
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.014.26
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.196.95
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.66.95
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.716.95
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52859.05Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.710.45382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.3810.76
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.810.76
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.110.76
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.655.93
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.855.82
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.345.82
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.768.0720,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.718.0720,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.618.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2417.91
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0917.91
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1317.91
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.618.72Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1817.4214,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.0212.986,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.117.64Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.116.75Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.716.23382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28281117,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.8512.857,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.213.18Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1519.4387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.813.89Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.488.717,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.6310.53
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.7212.36
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.1610.53
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3119.95
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1619.81
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7819.95
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3519.22392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.9812.16
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.6612.16
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.5313.64
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.1914.14
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.4814.14
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.814.1Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5216.01
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.516.847,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7419.81
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4919.81
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9426.96
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1640.766,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.842.83392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.636.14Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5539.317,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.249.35Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.240.767,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.135.01392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.827.17Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1523.047,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1523.047,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.917.56,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.0512.57392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.213.61,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.712.047,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.614.6392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9119.9518,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.820.981,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1218.67
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9218.67
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6818.63
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4518.727,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.6113.68
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.0613.64
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.313.64
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7521.64392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.4817.3719,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.216.58Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8319.867,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0819.35Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.922.46Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9221.93Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3222.75Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.219.72Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.5515.5Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2527.12Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3227.95Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7930.64Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3227.95Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.421.31Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3819.4Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0823.19Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7824.02Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1224.02Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4422.12Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0620.98Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.720.98Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9232.88Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2132.88Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3533.56Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5138.07Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0838.07Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244440Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.246.95Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.246.95Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8747.58Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.643.03Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6540.44Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6836.86Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.238.38Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.637.28Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514077.6Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.172.28Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.470.11Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279122.8Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.78105.83Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.4109.01Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.53107.06Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.15109.86Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.92109.86Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64114.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13114.94Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07116.28Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73116.28Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81114.05Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3114.05Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.94107.34Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.61107.34Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.56106.24Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.42109.29Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.76109.29Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.5107.2Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.2111.28Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58112.73Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23112.73Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.28110.71Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2142.62Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41138.16Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283119.65Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04121.21Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2496.96Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6895.84Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.299.1Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.8100.39Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.484.23Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.583.91Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1484.12Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538959.79Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338661.04Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4860.29Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3259.79Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7956.73Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1582.29Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7982.29Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.680.38Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7877.5Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5282.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9482.72Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3481.33Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2580.17Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8777.9Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.654.47Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9552.43Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8452.2Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8853.56Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7853.41Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.261.79Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3355.09Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8855.48Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5855.4Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2550.51Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.152.2Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9250.44Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179846.81Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6547.09Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6549.93Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0450.36Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1454.47Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8549.64Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7455.56Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2755.56Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6855.56Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9155.56Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6559.14Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010055.4Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4459.47Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8859.38Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.859.47Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8859.47Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0460.04Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1759.55Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1194.13
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1194.13
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6270.11
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8975.69
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199563.58
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9172.95
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6272.95
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8172.95
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4572.95
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.654.47
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5259.71
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7258.98
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.158.98
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4658.98
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8258.98
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2857.61
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6422.03
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9722.99
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.860.21
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5562.47
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.644.42
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3650.87
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3650.87
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.249.06
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8560.12
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0254.09
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1161.45
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1161.45
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.868.91
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9856.42
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9856.42
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.655.01
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.754.09
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3252.65
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.438.07
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3537.1
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4842.63
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6535.54
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0336.98
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0831.31
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460628.22
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1230.81
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125248
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1561.37
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20255.4
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0456.02
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7756.1
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4656.1
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0556.1
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2872.76
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522565.76
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.261.29
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6480.49
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0864.97
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.851.76
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1553.63
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2237.64
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1235.07
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1935.48
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4821.69
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8937.16
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9334.55
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4141.27
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8434.72
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4433.91
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9254.17
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8456.65
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.457.77
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2857.85
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5958.81
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3765.67
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9256.1
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9959.88
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1646.74
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018863.49
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9262.21
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2976.99
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8990.44
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8790.44
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.190.44
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0990.44
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7787.34
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6687.34
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.987.34
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6287.34
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.61100.52
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.02100.52
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.6100.52
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.84100.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.95100.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.95100.52
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4487
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.590.56
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2479.97
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4381.12
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1570.02
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8770.02
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.370.02
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2870.02
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2670.02
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.269.37
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1571.81
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8871.81
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.471.71
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0971.81
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4171.81
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1670.96
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2658.33
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1467.64
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.267.64
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7367.64
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0467.64
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0467.64
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5770.3
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5670.3
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0470.3
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6770.3
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5570.3
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4471.52
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8163.84
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8544.02
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4544.02
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1744.02
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0744.02
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.741.47
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3850.87
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8850.87
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1350.87
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2650.87
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72121.21Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21121.21Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17121.21Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79159Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21159Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK